Tamayo MS, Navarro MVR, Figueroa CR, García MYC, Crespo GA

Language: Spanish
References: 10
Page: 1-14
PDF size: 395.75 Kb.

ABSTRACT

Introduction: Among the limiting measures for COVID-19 is to avoid the entrance of possible ill people from territories with ongoing transmission.
Objective: To describe the experience of fitting out and functioning of active investigation points for the epidemiologic control of COVID-19 in the provincial borders of Cienfuegos province.
Methods: It was conducted a research in health systems and services in Cienfuegos province from March to May, 2020. The studied sample was formed by nine investigation points fit out in the borders. Interviews and participative observation were used as research techniques, and the statistics records of each active investigation point were also used.
Results: Nine points were fit out in the provincial borders which included a protocol for detection of respiratory symptomatic patients and their contacts, and these points had a physician, a technician in epidemiology, two volunteers of the Red Cross and a police officer. 33 891 people travelling in 16 678 vehicles were examined; 0,06% of them were suspicious to the disease, and 4,69% came back to their place of departure after the investigation and the educative intervention on needed social distancing.
Conclusions: Intersectoral participation was decisive to fit out border points which allowed to implement the investigation of all the travelers that arrived by road to Cienfuegos. Although the incidence of detected suspicious patients was low, the experience was positive and safe because it was part of the measures that reduced to minimun the virus spreading in the province.

REFERENCES

1. The Lancet Infectious Diseases group (Editorial). Challenges of coronavirus disease 2019. Lancet Infect Dis. 2020,20(3):261. DOI: 10.1016/S1473-3099(20)30072-4

2. Zhang S, Wang Z, Chang R, Wang H, Xu C, Yu X, et al. COVID-19 containment: China provides important lessons for global response. Front Med. 2020;14(2):215-219. DOI: 10.1007/s11684-020-0766-9

3. World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Geneva: WHO; 2020.

4. Peck KR. Early diagnosis and rapid isolation: response to COVID-19 outbreak in Korea. Clin Microbiol Infect. 2020;26(7):805-7. DOI: 10.1016/j.cmi.2020.04.025

5. Lee K, Worsnop CZ, Grépin KA, Kamradt-Scott A. Global coordination on cross-border travel and trade measures crucial to COVID-19 response. The Lancet. 2020;395 (10237):1593-95. DOI: 10.1016/S0140-6736(20)31032-1

6. Du Z, Wang L, Cauchemez S, Xu X, Wang X, Cowling BJ, Meyers LA. Risk for Transportationof Coronavirus Disease from Wuhan to Other Cities in China. Emerging Infectious Diseases. 2020;26(5):1049-52. DOI: 10.3201/eid2605.200146

7. Ministerio de Salud Pública de la República de Cuba. Plan para la prevención y control del nuevo coronavirus (COVID-19). La Habana: Minsap; 2020.

8. Navarro Machado VR, Moracén Rubio B, Santana Rodríguez D, Rodríguez González O, Oliva Santana M, Blanco González G. Pesquisa activa comunitaria ante la COVID-19. Experiencias en el municipio de Cumanayagua, 2020. Medisur. 2020 [acceso 20/05/2020];18(3). Disponible en: http://medisur.sld.cu/index.php/medisur/article/view/4654/3133

9. Gostic K, Gomez ACR, Mummah RO, Kucharski AJ, Lloyd-Smith JO. Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19. eLife. 2020;9:e55570. DOI: 10.7554/eLife.55570

10. Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? The Lancet. 2020;395:931-4. DOI: 10.1016/S0140-6736(20)30567-5